key: cord-0827737-uby0rgh9 authors: Brufsky, Adam title: Distinct Viral Clades of SARS‐CoV‐2: Implications for Modeling of Viral Spread date: 2020-04-20 journal: J Med Virol DOI: 10.1002/jmv.25902 sha: 1eba3880e79e9b14caa628d5fc98859d16db4afc doc_id: 827737 cord_uid: uby0rgh9 Distinct viral clades have a likely impact on COVID‐19 pathogenesis and spread. Sequence analysis from 2310 viral isolates from Nexstrain reveals that residue at 614 of the viral spike protein is changed from a putative ancestral aspartic acid (D) to a glycine (G) between two viral clades. The G strain is predominantly on the East Coast of the United States, and the D strain is predominantly on the West Coast. This mutation of the SARS‐CoV‐2 S protein spike is conserved in coronaviruses. Point mutations in a murine coronavirus spike protein can result in increased virulence through instability of the viral machinery and altered viral to cell membrane fusion. This observation may partially explain the discrepancy in predicted deaths from COVID‐19 between the East Coast and West Coast, and possibly explain that other factors aside from social distance, such as competition between two strains of differing virulence, may be at play. This article is protected by copyright. All rights reserved. and possibly explain that other factors aside from social distance, such as competition between two strains of differing virulence, may be at play. A current model of the COVID 19 epidemic 1 appears to have differing degrees of projected total deaths in various areas of the United States despite close timing of social distancing measures. For example, California with a population of approximately 40,000,000, began social distancing measures on March 19, 2020, yet is projected to plateau at 1,616 COVID 19 related deaths by May 15, 2020. New Jersey, by contrast, with a population of approximately 9,000,000, began social distancing measures on March 18, 2020 yet is projected to plateau at 3,915 COVID 19 related deaths by May 1, 2020. Factors other than social distancing may in part explain this discrepancy. These and other COVID 19 epidemic models appear to assume a universal basic reproductive number (R0) for virus spread, as well as a uniform degree of pathogenicity. A recent report 2 suggests the R0 of SARS-CoV-2 may be as high as 5.7, increased from the original estimated R0 of 2.28 3 . These reports also appear to assume a uniform pathogenicity and transmission of the virus through time and do not account for mutation of the virus either towards or away from a more virulent strain. As is typical of coronavirus, SARS-CoV-2 has rapidly acquired mutations allowing for tracking its ancestry and spread 4, 5 . For example, an S type of the virus accounted for only 3.7% of viral isolates in Wuhan compared to 96.3% of the L type yet isolates outside of Wuhan were 61.3% L type and 38.4% S type 4 . Examining clades of SARS-CoV-2 in 2310 geographically distributed viral DNA sequences using Nexstrain 5 (Figure 1 ) reveal that the B1 clade predominates on the West Coast of the United States, and the A2a clade, which apparently spread to New York through Europe and Italy if this limited viral sequence phylogeny analysis is correct, predominates on the East Coast. It has not escaped notice that these clades may vary in virulence. For example, analysis in Nexstrain in 2310 viral isolates of distribution of a non-synonymous mutation in the viral spike protein at codon 614 ( Figure 2 ) reveals that an aspartic acid (D) at this residue is predominant on the West Coast and a glycine (G) is predominant on the East Coast. SARS-CoV-2 genome phylogeny analysis reveals that this D614G mutation appeared to arise from an ancestral D residue (Figure 3 ). This mutation resides in a highly glycosylated region of the viral spike protein. A theory of viral pathogenesis 6 as well as cryogeneic electron microscopy (cryo EM) 7 and structure and function experiments 8 suggest the possibility that mutations in this region could alter this heavily glycosylated viral spike and alter membrane fusion in tissues, resulting in more pathogenicity and more human to human spread. This residue is highly conserved in coronaviruses 8 . There are many examples of mutation in this spike protein region resulting in changes in virulence 9,10 , and in particular a single serine to glycine change at residue 310 in a murine coronavirus spike protein resulted in increased virulence 11 through decreased stability of the viral fusion machinery. This analysis has clear limitations. Virus phylogeny studies, for example, can have sampling bias as well as statistical bias in the inference model used 12 . However, it should be relatively straightforward to test the virulence of various viral strains of SARS-CoV-2 in vitro, in particular those that have variability at residue 614 of the viral spike protein. This suggests that competition between viral strains of varying virulence may be at play during the COVID-19 pandemic. It is unclear whether current serologic or viral PCR based assays are able to detect this variability 8 . If this hypothesis is correct, it may be important to develop assays based on local viral clades, to determine the distribution of the virus and its spectrum of effects. It is may also be important for modelers to consider these possible variations in SARS-CoV-2 viral pathogenicity as models are developed for gradual relaxation of social restrictions. In particular, differences and timing of the activation of innate or adaptive immunity to the both viral strains as the pandemic progresses could be considered. IHME COVID-19 health service utilization forecasting team Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis On the origin and continuing evolution of SARS-CoV-2 Nextstrain: real-time tracking of pathogen evolution Hyperglycemia, and the COVID 19 Epidemic Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Disparate Regions of the Murine Coronavirus Spike Protein Impact the Initiation of Membrane Fusion The phylogenomics of evolving virus virulence